| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $-1.13 | $-1.54 | -36.4% |
| Q4'24 | $-1.16 | $-1.32 | -13.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $226M | $264M | +16.6% |
| Q4'24 | - | $104M | - |
Market Data
INSM is currently trading at $109.99, giving INSM a market cap of 31.72B. Today's range spans $144.50–$152.19, with shares opening at $147.24 and moving down $4.27 (3.7%) from the prior close. DailyIQ's technical score sits at 36/100 (HOLD) with a news sentiment reading of 72/100.
Over the past year INSM has traded between $60.40 and $212.75 - the current price is +82.1% off the 52-week low and -48.3% from the high.
INSM (INSM) has 31.72B in Healthcare market capitalization and is currently neutral on the technical dashboard: 36/100, HOLD, price $109.99 (in the lower half of its 52-week range). Sentiment reads bullish at 72/100. In this tier, quiet accumulation often happens in HOLD phases - active managers who want to build positions without signaling do it here, where the price isn't trending and volume patterns are easier to hide. Annual range: $60.40–$212.75.
Portfolio construction in Healthcare often uses large-cap names like INSM as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 36/100 (HOLD) at $109.99 (in the lower half of its 52-week range) and bullish sentiment (72/100) frame the position as a catalyst play within the $60.40–$212.75 annual range rather than a directional bet.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines